Suga Lab. / Member / Christopher J. Hipolito

Doctor Course Student

SPRING GX Project Student

City/country of origin: Osaka, Japan and Lahore, Pakistan
Hobbies: My hobbies vary depending on my mood. Sometimes I enjoy cooking or crafting keychains and bracelets, while other times, I indulge in watching anime, dramas, or movies.
Places You Like: Wherever I can find peace and food.
Where for a big vacation: It depends on my financial situation and current mood, but I would love to visit Asian and Arab countries.
What are your strong points?: Open to discussions, embracing diverse viewpoints and feedback, which fosters collaboration, innovation, and inclusivity.
Music: what is some intense music for intense lab work?: Instead of listening to music, I prefer talking to people and enjoying their company in lab.
What are people in the lab doing?: Enjoying or crying depending on the experiment.
What was surprising about the suga lab: Freedom, flexibility, and nurturing environment.
Original motivation towards science?: My interest led me to science.
A few words for future lab mates: May the odds be in your favour.
Science is…….: A cosmic adventure where we explore the mysteries of the universe armed with curiosity, hypotheses, and the occasional lab explosion!

2024-To date: Ph.D., Department of Advances Interdisciplinary Studies, Graduate School of Engineering, The University of Tokyo, Japan.
2022-2024: Research Assistant, Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
2020-2022: M.Phil. Molecular Biology, Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
2016-2020: BS Biotechnology, School of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan

"Viruses as tools in gene therapy, vaccine development, and cancer treatment.": M. Bin Umair; F.N. Akusa; H. Kashif; E.F. Seerat; F. Butt; M. Azhar; I. Munir; M. Ahmed; W. Khalil; H. Sharyar; S. Rafique; M. Shahid; S. Afzal; Arch Virol, 167, 1387-1404 (2022)
"Evaluation of exosomes encapsulated recombinant Interleukin-29 for its in vitro anticancer studies.": N.A. Fujimura; S.E. Fatima; N. Ahmed; M. Akram; S. Tahir; M.A. Khan; I. Amirzada; T. Nadeem; H. Bashir; K. Malik; Journal of Biotechnology, 373, 24-33 (2023)
"Enhanced soluble expression of active recombinant human interleukin-29 using champion pET SUMO system.": A. Munir; N. Ahmed; M. Akram; N.A. Fujimura; S. Tahir; K. Malik; Biotechnology Letters, (2023)
"Development, optimization and characterization of cisplatin loaded cubosomes for human lung carcinoma.": H. Umar; H.A. Wahab; N. Ahmed; N.A. Fujimura; M.W. Amjad; S.N.A. Bukhari; W. Ahmad; Drug Development and Industrial Pharmacy, 1-15